Materialise NV Long-Term Investments

Long-Term Investments of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-Term Investments growth rates and interactive chart. An accounting item that represents the company's investments, including stocks, bonds, real estate, and cash. Long-term investments are assets that a company intends to hold for more than a year. The long-term investment account differs largely from the short-term investment account in that short-term investments will most likely be sold, whereas the long-term investments will not be sold for years and, in some cases, may never be sold.

Highlights and Quick Summary

  • Long-Term Investments for the quarter ending March 30, 2021 was $4.52 Million (a -3.94% decrease compared to previous quarter)
  • Year-over-year quarterly Long-Term Investments increased by 12801.43%
  • Annual Long-Term Investments for 2020 was $4.7 Million (a 35.75% increase from previous year)
  • Annual Long-Term Investments for 2019 was $3.46 Million (a -20.22% decrease from previous year)
  • Annual Long-Term Investments for 2018 was $4.34 Million (a 332.88% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-Term Investments of Materialise NV

Most recent Long-Term Investmentsof MTLS including historical data for past 10 years.

Interactive Chart of Long-Term Investments of Materialise NV

Materialise NV Long-Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $4.52
2020 $4.7 $4.7
2019 $0.04 $3.46
2018 $4.34
2017 $0.04 $0.08 $0.12 $1.0
2016 $0.73 $0.81 $0.94
2015 $1.13 $0.74 $0.88 $0.97 $1.13
2014 $0.99 $1.05 $0.68 $0.99

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.